Neurogene Inc
Biotechnology
Healthcare
NGNE
21.00 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
17.14
52 week high
71.53
high
17.51
52 week low
0.00
low
16.77
growth
-58.65 %
previous Close
16.98
P/E ratio
-16
market cap
274 M
div yield
0
net incoming
-22.02 M
2.79 %
net profit margin
-2201600000.00 %
0.00 %
operating incoming
-26.08 M
-0.63 %
net change in cash
-11.96 M
81.83 %
cash on hand
58.81 M
-16.90 %
top